Patients with metastatic colorectal cancer can benefit from a variety of liver-directed treatment approaches, and some patients with stage IV disease can achieve durable remissions. Join us for a discussion-based CME moderated by Thomas Karasic, MD with representation from a multidisciplinary team of specialists from surgical oncology, radiation oncology, and interventional radiology to review the many options available for patients.

EDUCATIONAL OBJECTIVES

• Review evidence supporting liver-directed interventions in colorectal cancer
• Explore current and novel treatment approaches for colorectal liver metastases
• Discuss patient selection criteria for each therapy

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Penn Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Moderator: Thomas Karasic, MD

Panelists:
Ronald P. DeMatteo, MD, FACS
Robert E. Roses, MD
Michael C. Soulen, MD
Edgar Ben-Josef, MD